Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 137

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 137
---
 is, or will be, a party, to perform its obligations hereunder and thereunder, and, subject to the fulfillment of the terms prescribed in Section 6, to consummate the transactions contemplated hereby and thereby. The execution and delivery by TELI of this Agreement and the other Transaction Agreements to which it is a party or will be a party, and the consummation of the transactions contemplated hereby and thereby, have been duly and validly authorized by the TELI Board, and as of the Closing, by the TELI stockholders in accordance with Certificate of Incorporation of TELI, and no other corporate or similar proceedings on the part of TELI are necessary to authorize this Agreement and the other Transaction Agreements or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Transaction Agreement to which TELI is now or is to become a party has been or by the Effective Time will be, duly and validly executed and delivered by TELI and constitutes, assuming the due authorization, execution and delivery hereof and thereof by the Company and Merger Sub, the valid, legal and binding agreement of TELI, enforceable against it in accordance with its terms, except to the extent that enforceability may be limited by applicable bankruptcy, reorganization, insolvency, moratorium or other Applicable Laws affecting the enforcement of creditors’ rights generally and by general principles of equity, regardless of whether such enforceability is considered in a Proceeding at law or in equity.

3.3.1 Without limiting the generality of the foregoing, the TELI Board (i)has unanimously approved this Agreement, the Transaction Agreements and the transactions contemplated hereby and thereby, (ii)has made the TELI Recommendation, and (iii)has not, prior to the execution hereof, withdrawn or modified such approval (which approval has not been subsequently rescinded or modified in any way) or the TELI Recommendation.

3.3.2 The approval of TELI and TELI’s stockholders as approved in the TELI Stockholder Meeting, is the only vote of holders of any class or series of Capital Stock of TELI required in connection with the adoption of this Agreement and the consummation of the Merger and the other transactions contemplated hereby.

| 5 |

3.4 Financial Statements and Records.

3.4.0 TELI has no audited financial statements for 2025.

3.4.1 All stock